Medincell's Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026Business Wire • 09/21/26
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older PatientsGlobeNewsWire • 09/18/26
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare CostsGlobeNewsWire • 09/18/26
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in AdultsGlobeNewsWire • 09/18/26
Teva Pharmaceutical Industries Limited (TEVA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Teva Pharmaceuticals Sees Pivot to Growth Accelerating on Branded Drugs, BiosimilarsMarketBeat • 09/14/26
Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth StrategyGlobeNewsWire • 09/14/26
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial DisciplineGlobeNewsWire • 09/04/26
Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study TranscriptSeeking Alpha • 09/02/26
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product PotentialGlobeNewsWire • 09/02/26
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized DrugmakersZacks Investment Research • 09/01/26
Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.GlobeNewsWire • 08/31/26
Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset BidZacks Investment Research • 08/31/26